P-10 Oral Liquid

Category: Tags: , , , ,

Key Advantages:

✔ Cutting-Edge Formula

  • Novel quinolone structure with zero cross-resistance

  • Superior to traditional beta-lactams and earlier quinolones

✔ Unmatched Performance

  • Rapid systemic absorption – reaches therapeutic levels faster

  • Extended half-life – sustains effective concentrations longer

  • Broadest spectrum – covers Gram+, Gram-, and resistant strains

✔ Clinical Excellence

  • Specifically effective against beta-lactam resistant bacteria

  • Proven treatment outcomes in field conditions

  • Exceptional safety margin for all poultry categories


Therapeutic Applications:

Primary Indications:

  • Colibacillosis (resistant E. coli strains)

  • Salmonellosis (including multi-drug resistant Salmonella)

  • Chronic Respiratory Disease (CRD)

  • Bacterial enteritis

Target Pathogens:
✓ Gram-negative: E. coli, Salmonella, Pasteurella
✓ Gram-positive: Staphylococcus, Streptococcus
✓ Resistant strains failing conventional therapy


Dosage Protocol:

  • Standard Treatment: 10mg/kg body weight (1ml per 1L water) for 3-5 days

  • Severe Infections: As directed by poultry health professional

3rd Generation Quinolone for Poultry Health – Breakthrough Antibiotic Power

P-10 10% Oral Liquid represents a revolutionary advancement in poultry therapeutics as a newly synthesized quinolone carboxylic derivative. This 3rd generation antibiotic delivers unparalleled efficacy against resistant bacterial strains while maintaining exceptional safety profiles.

 

Why P-10 Stands Apart:
“Where other antibiotics fail, P-10 delivers. Our molecular design bypasses existing resistance mechanisms, offering poultry producers a reliable solution when conventional treatments disappoint.”

  • Dr. Avian Therapeutics, JULBEEB R&D

Color

Green, Yellow, Brown, White

About Us

Company

Careers

About

Stores

Team

Quick Links

Size Guide

Gift Cards

Check Gift Card Balance

Contact Us

© 2025 Created with Qdot Developers

Scroll to Top